Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in acute ITP in 1L treatment during COVID 19
Romiplostim thrombopoietin receptor agonist rapidly restores platelet counts in acute ITP in 1L treatment during COVID 19
Risk model predicts relapse after frontline blinatumomab in paediatric B-ALL
Epcoritamab induces deep and durable responses in chemotherapy-ineligible elderly patients with diffuse large B-cell lymphoma
Tafasitamab plus lenalidomide added to R-CHOP improves PFS in high-risk diffuse large B-cell lymphoma
Brentuximab vedotin added to CHEP improves response in CD30+ peripheral T-cell lymphomas
Blinatumomab replaces intensive chemo in high-risk paediatric ALL, improving survival
Gabapentin plus tramadol reduces opioid escalation for mucositis pain in head & neck cancer
Metronomic chemo plus nivolumab (TMC-I) improves survival in R/M head & neck cancer vs platinum chemotherapy
STRIDE ± lenvatinib plus TACE improves outcomes in unresectable early-to-intermediate HCC
Early ctDNA clearance linked to improved outcomes in KRAS G12C-mutant colorectal cancer
Giredestrant plus palbociclib shows limited benefit in ER-positive, HER2-negative metastatic breast cancer
Concurrent thoracic radiotherapy plus chemo-ICI shows no overall survival benefit in ES-SCLC